In our yet unpublished study, we analyzed Chk2 activation in peripheral blood mononuclear cells (PB-MNCs) isolated from several CML patients in the CP. This evidence concerns the gene CHEK2 and chronic myelogenous leukemia, BCR-ABL1 positive.